Search

Displaying results 9441 - 9450 of 10000 in total
  1. Drug

    Antroquinonol

    go.drugbank.com/drugs/DB12326
    Investigational

    Antroquinonol has been used in trials studying the treatment of Hyperlipidemias, Non-small Cell Lung Cancer, and Non-small Cell Lung Cancer Stage IV.

  2. Drug

    Pinometostat

    go.drugbank.com/drugs/DB12920
    Investigational

    Pinometostat has been used in trials studying the treatment of Leukemia, Acute Leukemias, Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Acute Lymphocytic Leukemia, among others.

  3. Drug

    Gemcitabine elaidate

    go.drugbank.com/drugs/DB12564
    Investigational

    Gemcitabine elaidate has been used in trials studying the treatment of Solid Tumor, Lung Cancer, Non-small-cell Lung Cancer, and Metastatic Pancreatic Adenocarcinoma.

  4. Drug

    Dipraglurant

    go.drugbank.com/drugs/DB12733
    Investigational

    Dipraglurant has been used in trials studying the treatment of Parkinson's Disease. It is a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM).

  5. Drug

    Brontictuzumab

    go.drugbank.com/drugs/DB12737
    Investigational

    Brontictuzumab has been used in trials studying the treatment of Adenoid Cystic Carcinoma, Relapsed or Refractory Solid Tumors, and Relapsed or Refractory Lymphoid Malignancies.

  6. Drug

    Crenigacestat

    go.drugbank.com/drugs/DB12050
    Investigational

    Crenigacestat has been used in trials studying the treatment and basic science of LYMPHOMA, Neoplasms, Solid Tumor, COLON CANCER, and BREAST CANCER, among others.

  7. Drug

    Trifluoroethanol

    go.drugbank.com/drugs/DB03226
    Experimental

    It is also used in various pharmaceutical, chemical and engineering applications.

  8. Drug

    Pipequaline

    go.drugbank.com/drugs/DB13991
    Experimental

    Pipequaline is an anticonflict & anticonvulsant quinoline derivative. It is an anxiolytic drug that was never marketed.

  9. Drug

    VA-MENGOC-BC®

    go.drugbank.com/drugs/DB15800
    Experimental

    This vaccine may also induce moderate protection against N. gonorrhoeae. As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials. … VA-MENGOC-BC is a meningococcal B and C vaccine and an outer membrane vesicle (OMV)-based vaccine.

  10. Drug

    GSK-2636771

    go.drugbank.com/drugs/DB11795
    Investigational

    GSK2636771 has been used in trials studying the treatment of CANCER, LYMPHOMA, Solid Neoplasm, Recurrent Solid Neoplasm, and Advanced Malignant Neoplasm, among others.